Efficacy and Safety of Neoadjuvant PD-1 Blockade with Sintilimab in Resectable Non-Small Cell Lung Cancer

被引:7
|
作者
Li, N. [1 ]
Ying, J. [1 ]
Tao, X. [1 ]
Zhang, F. [1 ]
Zhao, Z. [1 ]
Ling, Y. [1 ]
Gao, Y. [1 ]
Zhao, J. [1 ]
Xue, Q. [1 ]
Mao, Y. [1 ]
Lei, W. [1 ]
Wu, N. [1 ]
Wang, S. [1 ,4 ]
Duan, J. [1 ]
Gao, Y. [1 ]
Wang, Z. [1 ]
Sun, N. [1 ]
Wang, J. [1 ]
Gao, S. [2 ]
He, J. [1 ]
Zhou, H. [3 ]
Wang, S. [1 ,4 ]
机构
[1] Chinese Acad Med Sci, Canc Hosp, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Thorac Surg, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[3] Innovent Biol Suzhou Co Ltd, Suzhou, Peoples R China
[4] Innovent Biol, Suzhou, Peoples R China
关键词
Sintilimab; neoadjuvant; squamous NSCLC;
D O I
10.1016/j.jtho.2019.08.1322
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.18-06
引用
收藏
页码:S627 / S628
页数:2
相关论文
共 50 条
  • [1] Efficacy and Safety of Neoadjuvant PD-1 Blockade with Sintilimab in Resectable Squamous Non-Small Cell Lung Cancer (sqNSCLC)
    Li, N.
    Ying, J.
    Tao, X.
    Zhang, F.
    Zhao, Z.
    Ling, Y.
    Gao, Y.
    Zhao, J.
    Xue, Q.
    Mao, Y.
    Lei, W.
    Wu, N.
    Wang, S.
    Duan, J.
    Gao, Y.
    Wang, Z.
    Sun, N.
    Wang, J.
    Gao, S.
    He, J.
    Zhou, H.
    Wang, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S128 - S129
  • [2] Efficacy and safety of neoadjuvant PD-1 blockade with sintilimab in resectable squamous non-small cell lung cancer (sqNSCLC).
    Li, Ning
    Ying, Jianming
    Tao, Xiuli
    Zhang, Fan
    Zhao, Ziran
    Ling, Yun
    Gao, Yushun
    Zhao, Jun
    Xue, Qi
    Mao, Yousheng
    Lei, Wendong
    Wu, Ning
    Wang, Shuhang
    Duan, Jianchun
    Gao, Yibo
    Wang, Zhijie
    Sun, Nan
    Wang, Jie
    Gao, Shugeng
    He, Jie
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
    Yang, Xin
    Yin, Rong
    Xu, Lin
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (09):
  • [4] Neoadjuvant PD-1 blockade in resectable lung cancer
    Forde, Patrick M.
    Chaft, Jamie E.
    Smith, Kellie N.
    Anagnostou, Valsamo
    Cottrell, Tricia R.
    Hellmann, Matthew D.
    Zahurak, Marianna
    Yang, Stephen C.
    Jones, David R.
    Broderick, Stephen
    Battafarano, Richard J.
    Velez, Moises J.
    Rekhtman, Natasha
    Olah, Zachary
    Naidoo, Jarushka
    Marrone, Kristen A.
    Verde, Franco
    Guo, Haidan
    Zhang, Jiajia
    Caushi, Justina X.
    Chan, Hok Yee
    Sidhom, John-William
    Scharpf, Robert B.
    White, James
    Gabrielson, Edward
    Wang, Hao
    Rosner, Gary L.
    Rusch, Valerie
    Wolchok, Jedd D.
    Merghoub, Taha
    Taube, Janis M.
    Velculescu, Victor E.
    Topalian, Suzanne L.
    Brahmer, Julie R.
    Pardoll, Drew M.
    CANCER RESEARCH, 2018, 78 (13)
  • [5] Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
    Forde, P. M.
    Chaft, J. E.
    Smith, K. N.
    Anagnostou, V.
    Cottrell, T. R.
    Hellmann, M. D.
    Zahurak, M.
    Yang, S. C.
    Jones, D. R.
    Broderick, S.
    Battafarano, R. J.
    Velez, M. J.
    Rekhtman, N.
    Olah, Z.
    Naidoo, J.
    Marrone, K. A.
    Verde, F.
    Guo, H.
    Zhang, J.
    Caushi, J. X.
    Chan, H. Y.
    Sidhom, J. -W.
    Scharpf, R. B.
    White, J.
    Gabrielson, E.
    Wang, H.
    Rosner, G. L.
    Rusch, V.
    Wolchok, J. D.
    Merghoub, T.
    Taube, J. M.
    Velculescu, V. E.
    Topalian, S. L.
    Brahmer, J. R.
    Pardoll, D. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (21): : 1976 - 1986
  • [6] Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung Cancer
    Zhang, Peng
    Dai, Jie
    Sun, Fenghuan
    Xia, Haoran
    He, WenXin
    Duan, Liang
    Liu, Ming
    Zhao, Deping
    Zhu, Yuming
    Jiang, Gening
    ANNALS OF THORACIC SURGERY, 2022, 114 (03): : 949 - 958
  • [7] Neoadjuvant PD-1 Blockade in Non-Small Cell Lung Cancer: Current perspectives and Moving Forward
    Shinada, Kanako
    Murakami, Shuji
    ONCOTARGETS AND THERAPY, 2023, 16 : 99 - 108
  • [8] Predictive value of longitudinal systemic inflammatory markers for pathologic response to neoadjuvant PD-1 blockade in resectable non-small cell lung cancer
    Tao, Xiuli
    Zhang, Qian
    Yuan, Pei
    Wang, Shuhang
    Ying, Jianming
    Li, Ning
    Guo, Wei
    Li, Jing
    Guo, Lei
    Liu, Ying
    Zhang, Zewei
    Zhao, Shijun
    Gao, Shugeng
    Wu, Ning
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (11)
  • [9] Five-year follow-up of neoadjuvant PD-1 inhibitor (sintilimab) in non-small cell lung cancer
    Zhou, Bolun
    Zhang, Fan
    Guo, Wei
    Wang, Shuhang
    Li, Ning
    Qiu, Bin
    Zhao, Liang
    Li, Jian
    Shao, Kang
    Xue, Qi
    Lv, Fang
    Gao, Shugeng
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (08) : 1 - 9
  • [10] Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non-Small Cell Lung Cancer
    Zhang, Jiajia
    Ji, Zhicheng
    Caushi, Justina X.
    El Asmar, Margueritta
    Anagnostou, Valsamo
    Cottrell, Tricia R.
    Chan, Hok Yee
    Suri, Prerna
    Guo, Haidan
    Merghoub, Taha
    Chaft, Jamie E.
    Reuss, Joshua E.
    Tam, Ada J.
    Blosser, Richard L.
    Abu-Akeel, Mohsen
    Sidhom, John-William
    Zhao, Ni
    Ha, Jinny S.
    Jones, David R.
    Marrone, Kristen A.
    Naidoo, Jarushka
    Gabrielson, Edward
    Taube, Janis M.
    Velculescu, Victor E.
    Brahmer, Julie R.
    Housseau, Franck
    Hellmann, Matthew D.
    Forde, Patrick M.
    Pardoll, Drew M.
    Ji, Hongkai
    Smith, Kellie N.
    CLINICAL CANCER RESEARCH, 2020, 26 (06) : 1327 - 1337